Introduction
Oculocutaneous albinism (OCA) is a common inherited pigmentation disorder, caused by decreased or complete deficiency of pigmentation in the skin, hair and eyes [1] . Melanin is the pigment that gives brown color to skin,
OCA3
OCA3 (OMIM #203290) is a moderate form of albinism, also known as rufous/red OCA (ROCA) due to color of pigmentation. OCA3 is rare among Europeans, however it's estimated frequency is approximately 1:8500 in Africans [8] . Mutations in Tyrosinase related protein 1 (TYRP1) gene (OMIM#115501) causes OCA3 phenotypes. The TYRP1 gene (NG_011705.1) consists of 8 exons and spans 16 kb genomic DNA on chromosome 9p23. The TYRP1 gene encodes a 537 amino acids tyrosinase-related protein 1 (TRP1) of about 60,724 Da (UniProtKB # P17643), is expressed in melanocytes and mainly localized within melanosomes, where it may regulate the melanogenesis [11] . Although, the TRP1 shares 93% homology to its mouse ortholog (tyrp1) [12] , but significant differences are observed in their catalytic properties [13] . The exact catalytic function of TRP1 in melanin synthesis remains unclear. It forms a complex with tyrosinase that is important for normal intracellular trafficking and processing of tyrosine [14] , as a result this complex may suppress the premature death of melanocytes by reducing the tyrosinaseinduced cytotoxicity [11] . However in OCA3, mutations in TYRP1 gene lead to the production of an abnormally short, nonfunctional TRP1 that is retained within the endoplasmic reticulum (ER). Consequently, appropriate intracellular trafficking and processing of normal tyrosinase is delayed, leading to its proteasome-mediated degradation that results in significant hypopigmentation [15] .
tyrosine to L-dihydroxy-phenylalanine (DOPA) and then DOPA to DOPA-quinone or 5, 6-dihydroxyindole to indole-5,6 quinone [9] .
OCA1 is clinically divided into two subtypes: OCA1A (OMIM # 203100) that is characterized by complete loss of tyrosinase enzyme activity and OCA1B (OMIM # 606952) by decreased tyrosinase enzyme activity [6] .
OCA2
OCA2 (OMIM #203200) is the most common type of OCA in the world, also known as brown OCA (BOCA) due to color of pigmentation. OCA2 is more common particularly in Africa but less severe than OCA1, the estimated frequency of OCA2 is 1:3900-10 000 in Africans and 1:36 000 in Europeans [8] . Mutations in the OCA2 gene (OMIM # 611409) cause OCA2 phenotypes. The OCA2 gene (NG_009846.1) consists of 29 exons and spans 345kb genomic DNA on chromosome 15q12-q13. This gene encodes an 838 amino acids P protein of 92,850 Da (UniProtKB # Q04671), which is melanocyte-specific transporter protein with 12 predicted transmembrane domains. As a transporter protein, it may transport substrates or proteins including tyrosine or tyrosinase in the melanosome during melanin synthesis to regulate melanosomal pH or stabilize the melanosomal protein complex [1, 10] . Loss of function of P protein might disturb the availability of tyrosine or tyrosinase in the melanosomes in melanin synthesis that results in OCA2 phenotype. 
Role of Melanocyte-stimulating hormone receptor in melanin biosynthesis
The role of melanocyte-stimulating hormone receptor (MSH-R) is also very important in melanin biosynthesis [26] . The MSH-R is expressed from MC1R (Melanocortin Receptor 1) gene, after being assembled in the rough endoplasmic reticulum, undergoes a series of posttranslational modifications including oligomerization, glycosylation, palmitoylation and phosphorylation. The MSH-R is a seven pass transmembrane G protein coupled receptor primarily located on the surface of melanocytes, which are specialized cells that produce melanin. For melanin synthesis, two different ligands i.e., α-melanocyte stimulating hormone (αMSH) and agouti signaling protein (ASlP) bind with MSH-R, however, both ligands have opposite functions [27, 28] . Normally, binding of αMSH with MSH-R in response to ultraviolet light, stimulates integral membrane protein adenylate cyclase that results in the generation of secondary messenger cAMP. Consequently, activation of a cascade of reactions leads to the transcription of enzymes involved in brown/ black eumelanin production [26] . However, ASlP competes with α-MSH for binding to MSH-R, thereby, preventing the downstream expression of microphthalmia-associated transcription factor (MITF), which is the master regulator of enzymes (TRP1 and tyrosinase) involved in melanin
OCA4
OCA4 (OMIM #606574) is rare among Europeans and the estimated frequency is 1:85 000 in Japanese population [8] . Mutations in the Solute Carrier Family 45, Member 2 (SLC45A2 also known as MATP) gene (OMIM# 606202) cause OCA4 phenotypes. The SLC45A2 gene (NG_011691.2) consists of 10 exons and spans 40.5 kb genomic DNA on chromosome 5p13.2. This gene encodes a 530 amino acids Melanocyte-specific transporter protein known as "P" protein of about 58,286 Da (UniProtKB # Q9UMX9), and shares 82% sequence identity with its mouse ortholog [16] . The P protein has 12 putative transmembrane domains and transports proteins in the melanosomes that are necessary for melanin biosynthesis. Disease associated mutations identified in the SLC45A2 in Turkish, German, Japanese, and Korean OCA patients [16] [17] [18] [19] [20] , resulted in loss of function of P protein in OCA2 that might disturb the availability of tyrosinase in the melanosomes during melanogenesis [7] .
OCA5
OCA5 (OMIM# 615312) phenotype was discovered in the affected members of a consanguineous Pakistani family with OCA [21] . By genomewide linkage analysis, Kausar et al. [21] linked a susceptibility locus for OCA5 on chromosome 4q24, but couldn't identify an individual candidate as the causative gene.
OCA6
OCA6 (OMIM# 113750) is a new type of OCA. The data regarding estimated frequency of OCA6 has not yet been determined in the population, but this type has been reported in affected members of Chinese or Indian ancestry [5, 22] . Mutations in the Solute Carrier Family 24 (Sodium/ Potassium/Calcium Exchanger), Member 5 (SLC24A5) gene (OMIM # 609802) cause OCA6 phenotypes. The SLC24A5 (NG_011500.1) consists of 9 exons and spans 21.4 kb genomic DNA on chromosome 15q21.1. This gene encodes a 500 amino acids solute carrier protein of about 54,888 Da (UniProtKB # Q71RS6), and its orthologs have been found in mouse as well as in fish [23] . It may involve in the calcium homeostasis and intracellular calcium signaling in melanosomes that is necessary for the trafficking of proteins to melanosomes during melanin biosynthesis [23] [24] . Loss of function mutations in SLC24A5 disrupt melanosomal maturation and consequently melanin variants with the red hair color (RHC) phenotype was first reported by Valverde et al. [38] . The MC1R variants occur in high frequency in population as well as are enough to declare significance in association studies and depending on their penetrance for the RHC phenotype have been classified into various groups: strong "R" alleles that are highly penetrant, the weaker "r" forms that are less penetrant, and the pseudoalleles that do not have any obvious phenotype [39] . The well-known frequent MC1R strong variants are R151C, R160W and D294H whereas D84E and R142H are rare variants. The weaker RHC variants include V60L, V92M and R163Q [31] . A variant N281S is pseudoallele of MC1R. The RHC strong variants produce hypomorphic proteins that display decrease or completely absent ability to activate the cAMP pathway [40] . The study of RHC MC1R variants provided information about their association with other phenotypes and their effect on functioning of MSH-R has extended its role beyond pigmentation to diseased phenotypes. The MC1R variants, mainly the RHC alleles were also reported to be associated with increased risk of various types of melanoma [41] and UV induced susceptibility to skin damage [42] . The MC1R variants have been reported to be associated with pigmentary disorders including vitiligo [43] , severe photoaging [44] , congenital melanocytic nevi [45] and OCA [46] . However, association of MC1R variants with unrelated disorders have also been reported [40] . The MC1R variants associated with various disorders are summarized in Table 2 .
The melanocyte-stimulating hormone receptor has an extracellular N terminus, seven transmembrane helices with a series of intracellular and extracellular loops in between and intracellular C-terminus or cytosolic tail [31] . The highly conserved cysteine residues usually present at the N-terminus of melanocortin-1 receptor are usually synthesis. Thus, ASIP binding with MSH-R inhibits eumelanin synthesis and favors yellow/red pheomelanin synthesis [29] [30] [31] . However, the loss-of-function of MSH-R due to sequence variations in the MC1R gene may affect the ability to generate cAMP after stimulation with αMSH that results in minimal production of eumelanin in the melanocytes [32] .
Individuals with OCA who posses polymorphic gene variants of MC1R, mainly, produce pheomelanin or reduced amount of normal eumelanin [33] . Eumelanin provides photoprotection to the skin and eyes but pheomelanin provides little photo protection to these organs. Long-term exposure to sun significantly increases the risk of skin damage and skin cancer in individuals with OCA [34] . The pheomelanin production or reduced production of eumelanin in the eyes results in the incomplete development of eyes that produce ocular signs and symptoms in individuals with OCA [1, 3] . Therefore, the role of the MC1R seems to be very important in hypopigmentary disorders particularly OCA in humans.
The MC1R gene variants, associated phenotypes and affects on functioning of MSH-R
The MC1R gene (OMIM# 155555) was first mapped by Gantz et al. [35] to 16q24.3 by using fluorescence in situ hybridization (FISH). This MC1R is intronless gene (NG_012026.1) with a single exon of 3099 bp. The MSH-R encoded from this gene consists of 317-amino acids with molecular weight of 34,706 kD (UniProtKB # Q01726) that shares 76% sequence identity with its mouse ortholog, and is abundantly expressed in melanocytes [36] .
The MC1R gene is highly polymorphic, and more than 100 non synonymous variants have been documented in different populations [37] . The association of specific MC1R [50] and M128T [37, 56] have been identified in the third transmembrane helix of MSH-R. The association of I120T with disease phenotype is not known however; it leads to a moderate decrease of cAMP production after stimulation with αMSH. The V122M variant allele leads to partial loss-of-function of MSH-R whereas M128T variant allele leads to MSH-R being trafficked to the cell surface but unable to bind agonist efficiently and results in complete absence of functional coupling to the cAMP pathway.
An MC1R variant A166G [42] in the fourth transmembrane helix of MSH-R shows a moderate decrease of cAMP production after αMSH stimulation. The substitutions N281S [37] , C289R [37] and D294H [51, 53, 56, 60] in the seventh transmembrane helix of MSH-R have been reported. However, N281S is a functionally silent variant of MC1R, it does not affect receptor surface expression, agonist binding and agonistinduced signaling. The C289R variant in MC1R results in the expression of MSH-R that is trafficked to the cell surface but is unable to bind agonist efficiently leading to complete absence of functional coupling to the cAMP pathway. However, the D294H variant results in expression MSH-R that is unable to stimulate cAMP production in response to αMSH stimulation.
MC1R gene variants and their involvement in OCA
The partial loss-of-function mutations in the MC1R gene are most common among individuals of European ancestry with red or blond hair, freckles, light-colored skin that tans poorly and has an increased sensitivity to sun exposure [62] [63] [64] [65] . From evolutionary point of view, it is important that human migration out of Africa to areas of limited sun exposure, leads to selection for functionally relevant variants of pigmentation genes, including MC1R in Europeans [66] .
The same skin/hair/eye pigmentation variations have also been observed in individuals with OCA. However, these pigmentation variations usually compromise their significance in the diagnosis of the patients with OCA. But, the classical ocular symptoms of OCA are more specific and reliable in identifying patients with OCA. In many studies, it has been pointed out that the MC1R variants alone don't cause visual impairments in red-haired individuals. However, the MC1R variants in combination with OCA2 gene variants modify the OCA2 phenotype [32, 67] . glycosylated, because, when mutated to either glycine or alanine, leads to inactivation of receptor [47] [48] [49] . The cytosolic C-terminus is short and has potential sites such as Thr308 Cys315 and Ser316 for post-translation modifications as mutations at these sites may affect proper trafficking and functioning of receptor [31] . Among the three extracellular loops of melanocortin-1 receptor, the Loop 1 has many non-conserved residues that are prone to mutations while the second and third loops contain a number of conserved residues as mutations in these residues affect ligand binding during melanin synthesis [48, 49] .
The three intracellular loops of MSH-R have potential sites for binding of G-proteins and motifs for phosphorylation (a major determinant of MSH-R export) and mutations in loops at these key positions result in loss of function. A variant allele R67Q reported in first intracellular loop of MSH-R shows not a significant decrease of cAMP production in response to αMSH stimulation [42, 50] . On the second intracellular loop of MSH-R, variants including R142H [51] [52] F147Delta [42] , R151C [6, 42, 50, [51] [52] [53] [54] [55] , I155T [6, 56] , T157I and P159T [42] , R160W [6, 51, 53, [56] [57] R162P [58] , and R163Q [42, 50, 56] have been reported. Although the variants F147Delta, T157I and P159T make MSH-R unresponsive to αMSH stimulation and subsequently, there is a significant decrease in cAMP production. The R142H and R151C variants result in reduced expression of MSH-R at the cell surface that binds to αMSH but cannot be stimulated to produce cAMP. The variants R142H, R155T and R160W lead to reduced expression of MSH-R at the cell surface and show a moderate decrease of cAMP production due to αMSH stimulation.
The variants in the transmembrane helices of MSH-R also result in loss of function. The MC1R variant alleles identified in the first transmembrane helix domain of receptor are V38M [37] , I40T [58] , S41F [37, 56] , V51A [37] and V 60L [51, 53, 56, 59] . Among them V38M, S41F, V51A variants result in reduced cell surface expression of MSH-R as a consequence of retention in the endoplasmic reticulum and moderate decrease in coupling to the cAMP pathway. The variant V60L displays some residual binding ability of MSH-R to αMSH but unable to stimulate cAMP production where as I40T displays a partial loss-offunction of MSH-R.
The MC1R variants reported in the second transmembrane helix domain of MSH-R are D84E [6, 50, 60, 61] , V92M [42, 50, 53, 56, 59, 61] and L93R [52] . The D84E and V92M variants result in reduced expression of MSH-R at the cell surface and show moderate decrease of cAMP production in response to αMSH stimulation. The
In our previous study, we provided first evidence of sole involvement of MC1R gene variant that produced OCA2 phenotype in a Pakistani consanguineous family [46] . The affected individuals of this family have unusual reddish blonde hair, fair skin and freckles on faces, light brownish irises as well as ocular symptoms including astigmatism, photophobia, nystagmatism and decreased visual acuity. A novel mutation at postion (c.917G>A, p.Arg306His or R306H) in the MC1R gene was identified in homozygous condition only in the patients and the normal parents were the carriers of this mutation. The identification of inherited pathogenic MC1R mutation may possibly producing ocular dysfunction along with cutanous phenotype showed the first evidence of ocular involvement of MC1R gene.
The R306H variant resides in the short cytoplasmic tail or C-terminal of MSH-R that extends from His301 to Trp317. In this cytosolic tail the phosphorylation sites such as Thr308 and Ser316 are responsible for receptor internalization and desensitization [31, 68] . Moreover, in silico analysis has suggested that Cys315 in this tail is a highly palmitoylation site in MSH-R, as such modification regulates interactions and function of receptor. The C315A variant impairs significantly the number binding sites of MSH-R and agonist-mediated stimulation of cAMP synthesis [69] , whereas a C315G variant results in complete loss of function by disrupting the signaling of MSH-R but does not affect its binding to agonists [47] . Therefore, the inherited variation (R306H) in the MC1R in our previous study may be predicted to result in improper trafficking or King et al. [32] provided the first evidence of the involvement of MC1R variants in modification of the OCA phenotype in humans. They reported 8 probands with OCA2 with red hair at birth but red hair is unusual in OCA. The loss of function mutations were identified in both OCA2 and MC1R genes in only those probands who had persistent red hair. They concluded that mutations in the OCA2 gene were responsible for the classic phenotype of OCA2 in all probands and the sequence variations in the MC1R gene are associated with red hair thus, modify OCA phenotype in reported probands. Later on, Preising et al. [65] also provided the evidence of association of MC1R variants that modify OCA phenotype in another study. Among the all MC1R sequence variations reported, involvement of some variants in modification of OCA phenotypes has been reported, however, the molecular basis for their functional impairment remains mostly unknown. The variants in the single or compound heterozygous state reside in first (V60L) and second (R151C I155T, R160W, R163Q) intracellular loops and in second (D84E,V92M) and seven (D294H) transmembrane helices ( Figure 1 ) and they have been reported in individuals with OCA [32, 59] . All these variants in MC1R showed co-segregation with OCA2 variants in patients with OCA. As these variants reside in transmembrane helices and intracellular loops of MSH-R towards the cytoplasmic side, they were predicted to allow interaction with OCA2 protein. This interaction may influence transportation of a precursor (tyrosine or tyrosinase) in the melanosome during melanin biosynthesis [65, 67] . loss of function of MSH-R thereby affecting either agonistinduced phosphorylation or palmitoylation modification respectively.
Conclusions
This review will help us to understand, further, the classification of the OCA and the function of MC1R gene establishing genotype phenotype association. Still, there is a need of functional studies that will help clarify MC1R gene variants and their involvement in OCA. Clinical differentiation of OCA types has been difficult due to the observed range of phenotypic variations. Thus, genetic analysis may be helpful with respect to a precise diagnosis. In consanguineous families with OCA phenotype, carrier diagnosis and genetic counseling may be helpful in reducing the chances of babies with OCA.
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